Results 201 to 210 of about 2,605,325 (333)
Low‐Cost New Glaucoma Drainage Device in Indonesia: One Year Follow‐Up of 252 Subjects
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background To evaluate the early efficacy and safety of a new polymethyl methacrylate 200 mm2 non‐valved glaucoma drainage device (GDD) designed for Indonesian use over a 12 month period. Methods This was a prospective study following subjects with various forms of refractory glaucoma aged ≥ 7 years old followed for 12 months. The subjects had
Virna Dwi Oktariana Asrory +1 more
wiley +1 more source
Cataract Surgery in the Small Adult Eye: A Review
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Modern cataract surgery continues to advance, yet intraocular lens (IOL) based surgery in the small adult eye remains challenging. Thorough preoperative assessment and surgical preparation optimise postoperative outcomes in these cases. Advances in IOL power calculation, including artificial intelligence‐driven formulas, improve accuracy ...
Jonathan E. Moore +2 more
wiley +1 more source
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background To identify evidence on the use of topical CsA for ocular surface diseases (OSD). Methods A literature search was conducted following the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) through June 2023 via Cochrane Central Registries, Clinical Trials Registry, Grey literature and citation searching ...
Ngozi C. Chidi‐Egboka +10 more
wiley +1 more source
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang +8 more
wiley +1 more source
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background The study objective was to compare the effectiveness of adalimumab (ADA) in monotherapy and in combination with methotrexate (MTX) for paediatric noninfectious uveitis (NIU). Methods Registry‐based observational study. Children receiving ADA for active uveitis were divided into the ADA monotherapy group (group 1) and the ADA plus ...
Carla Gaggiano +40 more
wiley +1 more source
Presbyopia Correction in Lens Replacement Surgery: A Review
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Presbyopia affects approximately 1.8 billion individuals globally, posing significant challenges as life expectancy and near‐vision demands, particularly with mobile phone use, grow. Addressing presbyopia during lens replacement surgery has become a key focus for cataract surgeons, aiming to reduce dependence on corrective eyewear. This review
Benjamin Stern, Damien Gatinel
wiley +1 more source
Long‐Term Morphological Changes of Crosslinked Gelatin Stent
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background This study investigates the long‐term morphological outcomes of crosslinked gelatin stents over a 10‐year period. Methods Participants from the FDA phase 1 and 2 trials for the XEN 140 stent were recalled for follow‐up examinations between 9 and 12 years after their initial implantation.
Yuen Keat Gan +3 more
wiley +1 more source
Clinical Genetics, EarlyView.Early‐onset Marfan syndrome (eoMFS) is a rare disorder with atrioventricular valve insufficiency being the most severe symptom. We propose to regard eoMFS as a spectrum, ranging from a severe disorder life‐threatening already before or immediately after birth, to a disorder with a better survival rate, creating a window for atrioventricular valve ...
Eva C. van der Leest +12 more
wiley +1 more source
Clinical Genetics, EarlyView.Cerebrotendinous xanthomatosis is due to biallelic pathogenic variants in CYP27A1. We report a new patient and his good neurocognitive outcome on the chenodeoxycholic acid treatment despite therapy starting at the age of 34 years. This highlights the importance of recognizing treatable inherited metabolic diseases at any age.
Randa Sultan +6 more
wiley +1 more source
Identification of Genetic Variants Causing Paediatric Cataract in Myanmar
Clinical Genetics, EarlyView.Up to 60% of children with cataract in Myanmar have a causative variant in a known cataract gene. This is a similar rate to other populations screened to date, but highlights that there are more cataract genes left to identify. ABSTRACT Genetic testing for paediatric cataract detects a cause in 50%–70% of affected children but is as low as 20% in some ...
Johanna L. Jones +16 more
wiley +1 more source